<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?subarticle S01?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Einstein (Sao Paulo)</journal-id><journal-id journal-id-type="iso-abbrev">Einstein (Sao Paulo)</journal-id><journal-id journal-id-type="publisher-id">eins</journal-id><journal-title-group><journal-title>Einstein</journal-title></journal-title-group><issn pub-type="ppub">1679-4508</issn><issn pub-type="epub">2317-6385</issn><publisher><publisher-name>Instituto Israelita de Ensino e Pesquisa Albert Einstein</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6910063</article-id><article-id pub-id-type="other">00224</article-id><article-id pub-id-type="doi">10.31744/einstein_journal/2020AO5078</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Performance evaluation of an indirect immunofluorescence kit for the serological diagnosis of dengue</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2929-5394</contrib-id><name><surname>Arai</surname><given-names>Karina Emy</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9267-3282</contrib-id><name><surname>Bo</surname><given-names>Carolina Rodrigues Dal</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0281-4302</contrib-id><name><surname>da Silva</surname><given-names>Ana Paula Marques Aguirra</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6619-7836</contrib-id><name><surname>Rodrigues</surname><given-names>Silvia Sanches</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4227-3723</contrib-id><name><surname>Mangueira</surname><given-names>Crist&#x000f3;v&#x000e3;o Luis Pitangueira</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><aff id="aff1">
<label>1</label>
Faculdade Israelita de Ci&#x000ea;ncias da Sa&#x000fa;de Albert Einstein, Hospital Israelita Albert Einstein, S&#x000e3;o Paulo, SP, Brazil</aff><aff id="aff2">
<label>2</label>
Hospital Israelita Albert Einstein, S&#x000e3;o Paulo, SP, Brazil</aff></contrib-group><author-notes><corresp id="c1"><bold>Corresponding author:</bold> Karina Emy Arai, Rua Madre Cabrini, 332 &#x02013; Vila Mariana Zip code: <postal-code>04020-001</postal-code> &#x02013; S&#x000e3;o Paulo, SP, Brazil Phone: <phone>(55 11) 98999-4555</phone> E-mail: <email>karinaemyarai@gmail.com</email></corresp><fn fn-type="COI-statement"><p><bold>Conflict of interest:</bold> none.</p></fn></author-notes><pub-date publication-format="electronic" date-type="pub"><day>10</day><month>12</month><year>2019</year></pub-date><pub-date publication-format="electronic" date-type="collection"><year>2020</year></pub-date><volume>18</volume><elocation-id>eAO5078</elocation-id><history><date date-type="received"><day>20</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>21</day><month>8</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This content is licensed under a Creative Commons Attribution 4.0 International License.</license-p></license></permissions><abstract><title>ABSTRACT</title><sec><title>Objective:</title><p>To evaluate the performance of indirect immunofluorescence for serological diagnosis of dengue virus in a population with high prevalence of arboviruses.</p></sec><sec><title>Methods:</title><p>Two-hundred serum samples from patients with clinical suspicion of dengue fever were tested by immunoenzymatic and indirect immunofluorescence assay BIOCHIP&#x000ae; mosaic. Specificity, sensitivity and Kappa coefficient were calculated. Discordant samples were tested by polymerase chain reaction for confirmation.</p></sec><sec><title>Results:</title><p>Of the 200 samples, 20% were positive and 80% negative for anti-dengue virus IgM antibodies in the immunoenzymatic test. Of the 40 positives, 25% were negative in indirect immunofluorescence. Of these ten discordant results, only 20% were also negative in the polymerase chain reaction (PCR). Of the 160 negatives in the immunoenzymatic test, 5% were positive in indirect immunofluorescence. Of these nine discordant results, 33% were positive in the PCR. The Kappa coefficient was 0.7 (0.572-0.829). Sensitivity and specificity of indirect immunofluorescence were respectively 75% and 94%. For anti-dengue virus IgG antibodies, of the 200 samples, 15.5% were positive and 84.5% were negative in the immunoenzymatic test. Of the 31 positives, 12.9% were negative in indirect immunofluorescence. Of these four discordant results, 25% were negative in the PCR. Of the 169 negatives, 8% were positive in indirect immunofluorescence. Of these 14 discordant results, 64% were also positive in the PCR. The Kappa coefficient was 0.695 (0.563-0.83). Sensitivity and specificity of indirect immunofluorescence were 87.1% and 91.7%, respectively.</p></sec><sec><title>Conclusion:</title><p>For diagnosis of acute infection, the immunoenzymatic test is enough, and the use of additional methods is not warranted. Replacing the immunoenzymatic test by indirect immunofluorescence would compromise the sensitivity for IgM. However, indirect immunofluorescence can distinguish three arboviruses simultaneously, an advantage during concomitant epidemics.</p></sec></abstract><kwd-group><title>Keywords:</title><kwd>Arbovirus infections</kwd><kwd>Dengue</kwd><kwd>Enzyme-linked immunosorbent assay</kwd><kwd>Serologic tests</kwd><kwd>Fluorescent antibody technique</kwd><kwd>indirect</kwd></kwd-group><counts><fig-count count="0"/><table-count count="4"/><equation-count count="0"/><ref-count count="16"/></counts></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Dengue fever, an arbovirus infection predominantly transmitted by vectors of the <italic>Aedes aegypti</italic> species, is a serious public health issue in Brazil, with seasonal epidemics virtually across the entire national territory.<sup>(</sup><xref rid="B1" ref-type="bibr"><sup>1</sup></xref><sup>)</sup> The country recorded 572,308 probable cases in 2014; 1,621,797 in 2015; 1,483,623 in 2016; 251,711 in 2017 and 265,934 in 2018.<sup>(</sup><xref rid="B2" ref-type="bibr"><sup>2</sup></xref><sup>&#x02013;</sup><xref rid="B4" ref-type="bibr"><sup>4</sup></xref><sup>)</sup> All four serotypes of the dengue virus are present in Brazil.</p><p>Laboratory screening for the dengue virus mostly involves techniques of viral isolation, identification of dengue virus (DENV)-specific antibodies using serologic tests, direct identification of viral RNA, and detection of the NS1 antigen.<sup>(</sup><xref rid="B5" ref-type="bibr"><sup>5</sup></xref><sup>&#x02013;</sup><xref rid="B7" ref-type="bibr"><sup>7</sup></xref><sup>)</sup></p><p>The serologic diagnosis of acute infection is based on detection of DENV-specific immunoglobulin M (IgM), detectable in 93% of cases, 6 to 10 days after the onset of fever.<sup>(</sup><xref rid="B8" ref-type="bibr"><sup>8</sup></xref><sup>)</sup> Dengue virus-specific immunoglobulin G (IgG) can be detected in current infections if, at the time the test is performed, seroconversion has already taken place, and is otherwise useful to check for past infections. The IgG avidity test helps differentiate between primary and secondary infections by the dengue virus.<sup>(</sup><xref rid="B6" ref-type="bibr"><sup>6</sup></xref><sup>)</sup></p><p>The Enzyme-Linked Immunosorbent Assay (ELISA) is currently the most commonly used serologic test in clinical laboratories. It is a simple, quick test requiring limited high-tech equipment.<sup>(</sup><xref rid="B9" ref-type="bibr"><sup>9</sup></xref><sup>&#x02013;</sup><xref rid="B11" ref-type="bibr"><sup>11</sup></xref><sup>)</sup> During an epidemic, the ELISA assay can quickly determine the extent of transmission. In dengue-endemic areas, this test can be used to screen a large number of serum samples at low costs.<sup>(</sup><xref rid="B9" ref-type="bibr"><sup>9</sup></xref><sup>)</sup></p><p>Indirect immunofluorescence is another serologic method to identify dengue virus-specific IgM and IgG antibodies, however few studies<sup>(</sup><xref rid="B12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="B13" ref-type="bibr"><sup>13</sup></xref><sup>)</sup> have investigated the use of this test. Most serologic tests available in clinical laboratories in Brazil were developed abroad, and their validation studies were frequently conducted in populations in which the disease is not highly prevalent and which have not experienced concomitant outbreaks of other arboviruses, such as Zika and Chikungunya, and this could lead to false-positive results for dengue virus due to cross-reactive antibodies, hindering diagnosis.<sup>(</sup><xref rid="B14" ref-type="bibr"><sup>14</sup></xref><sup>)</sup></p><p>During the dengue fever epidemics in 2016, a new indirect immunofluorescence (IIF) test, the BIOCHIP<sup>&#x000ae;</sup> mosaic developed in Germany and promising to serologically detect the dengue, Zika and Chikungunya viruses, was released in Brazil to compete with ELISA assays, which had been used as routine for a longer time.</p></sec><sec><title>OBJECTIVE</title><p>To evaluate the diagnostic performance of an indirect immunofluorescence assay for serologic diagnosis of the dengue virus in a population with high prevalence of arboviruses, in comparison with the ELISA serologic test.</p></sec><sec sec-type="methods"><title>METHODS</title><p>We used 200 serum samples from routine testing at the Clinical Laboratory of <italic>Hospital Israelita Albert Einstein</italic> (HIAE), collected in 2014 and sent to the laboratory due to clinical suspicion of infection by the dengue virus. Samples were characterized at the time as negative or positive for dengue virus using ELISA (Foccus, USA). All samples were tested with the BIOCHIP<sup>&#x000ae;</sup> mosaic IIF technique (Euroimmun, Germany).</p><p>The appropriate statistical tools (EP Evaluator software) were used to calculate pre-test probabilities: sensitivity (diagnostic test's ability to detect true positive) and specificity (diagnostic test's ability to detect true negative). We also calculated post-test probabilities: positive predictive value (rate of patients with positive tests who effectively have the disease according to the gold standard test), negative predictive value (rate of patients with negative tests who effectively do not have the disease according to the gold standard test). Finally, we calculated accuracy, which is the probability of the test providing correct results, and the Kappa coefficient, a measure of the level of agreement between two methods, adjusted by the odds, <italic>i.e.,</italic> it informs the non-random chance, ranging from &#x02212;1 to 1, where 0.00 is no agreement, 0.00-0.20 is poor agreement, 0.21-0.40 fair agreement, 0.41-0.60 moderate agreement, 0.61-0.80 good agreement, 0.81-0.99 very good agreement, and 1 is perfect agreement.<sup>(</sup><xref rid="B15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="B16" ref-type="bibr"><sup>16</sup></xref><sup>)</sup></p><p>In samples for which the two methods were discordant, we used polymerase chain reaction (PCR) as a confirmatory diagnostic method. Polymerase chain reaction is a molecular assay which quantitatively detects DENV RNA, and is considered the gold standard, since it can effectively prove that the virus is present in the body. However, it has limitations, including its high cost, which prevents it from being routinely used for screening in laboratories.<sup>(</sup><xref rid="B5" ref-type="bibr"><sup>5</sup></xref><sup>)</sup></p><p>This study was approved by the Institutional Review Board of <italic>Hospital Israelita Albert Einstein</italic>, CAAE: 83521718.5.0000.0071, opinion n&#x000ba; 2.909.625.</p></sec><sec sec-type="results"><title>RESULTS</title><p>Of the 200 samples studied, 40 (20%) were classified as positive and 160 (80%) as negative for anti-DENV IgM antibodies, in the reference ELISA test.</p><p>Of the 40 positive samples, 10 (25%) were negative in the IIF test; of these 10 discordant samples, only 2 (20%) were also negative in the PCR. However, of the 160 negative samples in the reference ELISA, 9 (5%) were positive in the IIF test; of these 9 discordant samples, 3 (33%) were positive for DENV in the PCR (<xref rid="t1" ref-type="table">Table 1</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Detection of anti-dengue virus IgM antibodies in the ELISA and indirect immunofluorescence tests</title></caption><table frame="hsides" rules="groups"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr style="background-color:#ADC9EA"><th align="left" rowspan="2" valign="middle" colspan="1">IgM indirect immunofluorescence</th><th align="center" colspan="2" style="border-bottom: thin solid; border-color: #000000" rowspan="1">IgM ELISA</th><th align="center" rowspan="2" valign="middle" colspan="1">Total</th></tr><tr style="background-color:#ADC9EA"><th align="center" rowspan="1" colspan="1">Positive</th><th align="center" rowspan="1" colspan="1">Negative</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr style="background-color:#E1ECF8"><td align="left" rowspan="1" colspan="1">Positive</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">39</td></tr><tr><td align="left" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">151</td><td align="center" rowspan="1" colspan="1">161</td></tr><tr style="background-color:#E1ECF8"><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">160</td><td align="center" rowspan="1" colspan="1">200</td></tr></tbody></table></table-wrap><p>When the Kappa test was used on results from both assays, an agreement level of 0.7 (0.572-0.829) was found. Sensitivity and specificity of indirect immunofluorescence was 75% and 94%, respectively. The positive predictive value of IIF was 76.9%, the negative predictive value was 93.7%, and the accuracy, 90.5%.</p><p>For anti-DENV IgG antibodies, of the 200 serum samples, 31 (15.5%) were classified as positive and 169 (84.5%) as negative, in the ELISA test. Of the 31 positive samples, 4 (12.9%) were negative in the IIF test; of these 4 discordant samples, only 1 (25%) had undetectable DENV in the PCR. However, of the 169 negative samples, 14 (8%) were positive in the IIF test; of these 14 discordant samples, 9 (64%) were also positive in the PCR (<xref rid="t2" ref-type="table">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Detection of anti-dengue virus IgG antibodies. Comparison between ELISA and indirect immunofluorescence results</title></caption><table frame="hsides" rules="groups"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr style="background-color:#ADC9EA"><th align="left" rowspan="2" valign="middle" colspan="1">IgG indirect immunofluorescence</th><th align="center" colspan="2" style="border-bottom: thin solid; border-color: #000000" rowspan="1">IgG ELISA</th><th align="center" rowspan="2" valign="middle" colspan="1">Total</th></tr><tr style="background-color:#ADC9EA"><th align="center" rowspan="1" colspan="1">Reagent</th><th align="center" rowspan="1" colspan="1">Non reagent</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr style="background-color:#E1ECF8"><td align="left" rowspan="1" colspan="1">Reagent</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">41</td></tr><tr><td align="left" rowspan="1" colspan="1">Non reagent</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">155</td><td align="center" rowspan="1" colspan="1">159</td></tr><tr style="background-color:#E1ECF8"><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">169</td><td align="center" rowspan="1" colspan="1">200</td></tr></tbody></table></table-wrap><p>When the Kappa test was used on results from both assays, an agreement level of 0.695 (0.563-0.83) was found. The sensitivity and specificity of indirect immunofluorescence was 87.1% and 91.7%, respectively. The positive predictive value of IIF was 65.8%, the negative predictive value was 97.4%, and accuracy, 91%.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The level of agreement, as verified by the Kappa coefficient, between the new IIF test and the test used as reference ELISA was acceptable, attesting to the good performance of the new test.</p><p>However, PCR, which was the method used to confirm the presence of viral antigens in samples for which the two methods were discordant, showed higher agreement with ELISA in most cases, except those with negative ELISA and positive IIF for anti-DENV IgG antibodies (false-positive IgG), where the PCR was 64% concordant with indirect immunofluorescence.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Indirect immunofluorescence has acceptable performance, however, for clinically relevant situations, when diagnosing acute infection (detection of IgM antibodies), ELISA alone is sufficient for serologic diagnosis, and the use of an additional method is not warranted. Replacing ELISA with indirect immunofluorescence, in turn, could compromise diagnostic sensitivity, increasing the number of false-negative samples for IgM.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="journal" id="B1-gen-2"><person-group person-group-type="author"><name><surname>Bhatt</surname><given-names>S</given-names></name><name><surname>Gething</surname><given-names>PW</given-names></name><name><surname>Brady</surname><given-names>OJ</given-names></name><name><surname>Messina</surname><given-names>JP</given-names></name><name><surname>Farlow</surname><given-names>AW</given-names></name><name><surname>Moyes</surname><given-names>CL</given-names></name><etal/></person-group><article-title>The global distribution and burden of dengue</article-title><source>Nature</source><year>2013</year><volume>496</volume><issue>7446</issue><fpage>504</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">23563266</pub-id></element-citation><mixed-citation publication-type="other" id="B1-gen-3">1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504-7.</mixed-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal" id="B2-gen-2"><person-group person-group-type="author"><collab>Brasil. Minist&#x000e9;rio da Sa&#x000fa;de. Secretaria de Vigil&#x000e2;ncia em Sa&#x000fa;de</collab></person-group><article-title>Monitoramento dos casos de dengue, febre de chikungunya e febre pelo v&#x000ed;rus Zika at&#x000e9; a Semana Epidemiol&#x000f3;gica 7 de 2018</article-title><source>Boletim Epidemiol&#x000f3;gico</source><year>2018</year><volume>49</volume><issue>9</issue><fpage>1</fpage><lpage>13</lpage></element-citation><mixed-citation publication-type="other" id="B2-gen-3">2. Brasil. Minist&#x000e9;rio da Sa&#x000fa;de. Secretaria de Vigil&#x000e2;ncia em Sa&#x000fa;de. Monitoramento dos casos de dengue, febre de chikungunya e febre pelo v&#x000ed;rus Zika at&#x000e9; a Semana Epidemiol&#x000f3;gica 7 de 2018. Boletim Epidemiol&#x000f3;gico. 2018;49(9):1-13.</mixed-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal" id="B3-gen-2"><person-group person-group-type="author"><collab>Brasil. Minist&#x000e9;rio da Sa&#x000fa;de. Secretaria de Vigil&#x000e2;ncia em Sa&#x000fa;de</collab></person-group><article-title>Monitoramento dos casos de dengue, febre de chikungunya e febre pelo v&#x000ed;rus Zika at&#x000e9; a Semana Epidemiol&#x000f3;gica 51, 2015</article-title><source>Boletim Epidemiol&#x000f3;gico</source><year>2016</year><volume>47</volume><issue>2</issue><fpage>1</fpage><lpage>9</lpage></element-citation><mixed-citation publication-type="other" id="B3-gen-3">3. Brasil. Minist&#x000e9;rio da Sa&#x000fa;de. Secretaria de Vigil&#x000e2;ncia em Sa&#x000fa;de. Monitoramento dos casos de dengue, febre de chikungunya e febre pelo v&#x000ed;rus Zika at&#x000e9; a Semana Epidemiol&#x000f3;gica 51, 2015. Boletim Epidemiol&#x000f3;gico. 2016;47(2):1-9.</mixed-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal" id="B4-gen-2"><person-group person-group-type="author"><collab>Brasil. Minist&#x000e9;rio da Sa&#x000fa;de. Secretaria de Vigil&#x000e2;ncia em Sa&#x000fa;de</collab></person-group><article-title>Monitoramento dos casos de dengue, febre de chikungunya e febre pelo v&#x000ed;rus Zika at&#x000e9; a Semana Epidemiol&#x000f3;gica 52 de 2018</article-title><source>Boletim Epidemiol&#x000f3;gico</source><year>2019</year><volume>50</volume><issue>4</issue><fpage>1</fpage><lpage>14</lpage></element-citation><mixed-citation publication-type="other" id="B4-gen-3">4. Brasil. Minist&#x000e9;rio da Sa&#x000fa;de. Secretaria de Vigil&#x000e2;ncia em Sa&#x000fa;de. Monitoramento dos casos de dengue, febre de chikungunya e febre pelo v&#x000ed;rus Zika at&#x000e9; a Semana Epidemiol&#x000f3;gica 52 de 2018. Boletim Epidemiol&#x000f3;gico. 2019;50(4):1-14.</mixed-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal" id="B5-gen-2"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>CL</given-names></name><name><surname>Wu</surname><given-names>MC</given-names></name><name><surname>Chiu</surname><given-names>YH</given-names></name><name><surname>Lin</surname><given-names>JL</given-names></name><name><surname>Wu</surname><given-names>YC</given-names></name><name><surname>Yueh</surname><given-names>YY</given-names></name><etal/></person-group><article-title>Flow cytometry compared with indirect immunofluorescence for rapid detection of dengue virus type 1 after amplification in tissue culture</article-title><source>J Clin Microbiol</source><year>2001</year><volume>39</volume><issue>10</issue><fpage>3672</fpage><lpage>3677</lpage><pub-id pub-id-type="pmid">11574589</pub-id></element-citation><mixed-citation publication-type="other" id="B5-gen-3">5. Kao CL, Wu MC, Chiu YH, Lin JL, Wu YC, Yueh YY, et al. Flow cytometry compared with indirect immunofluorescence for rapid detection of dengue virus type 1 after amplification in tissue culture. J Clin Microbiol. 2001;39(10):3672-7.</mixed-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal" id="B6-gen-2"><person-group person-group-type="author"><name><surname>Peeling</surname><given-names>RW</given-names></name><name><surname>Artsob</surname><given-names>H</given-names></name><name><surname>Pelegrino</surname><given-names>JL</given-names></name><name><surname>Buchy</surname><given-names>P</given-names></name><name><surname>Cardosa</surname><given-names>MJ</given-names></name><name><surname>Devi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Evaluation of diagnostic tests: dengue</article-title><source>Nat Rev Microbiol</source><year>2010</year><volume>8</volume><issue>12 Supp</issue><fpage>S30</fpage><lpage>S38</lpage><pub-id pub-id-type="pmid">21548185</pub-id></element-citation><mixed-citation publication-type="other" id="B6-gen-3">6. Peeling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, Devi S, et al. Evaluation of diagnostic tests: dengue. Nat Rev Microbiol. 2010;8(12 Supp):S30-8.</mixed-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal" id="B7-gen-2"><person-group person-group-type="author"><name><surname>Henchal</surname><given-names>EA</given-names></name><name><surname>Putnak</surname><given-names>JR</given-names></name></person-group><article-title>The dengue viruses</article-title><source>Clin Microbiol Rev</source><year>1990</year><volume>3</volume><issue>4</issue><fpage>376</fpage><lpage>396</lpage><comment>Review</comment><pub-id pub-id-type="pmid">2224837</pub-id></element-citation><mixed-citation publication-type="other" id="B7-gen-3">7. Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev. 1990;3(4):376-96. Review.</mixed-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal" id="B8-gen-2"><person-group person-group-type="author"><name><surname>Kuno</surname><given-names>G</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>I</given-names></name><name><surname>Gubler</surname><given-names>DJ</given-names></name></person-group><article-title>An ELISA procedure for the diagnosis of dengue infections</article-title><source>J Virol Methods</source><year>1991</year><volume>33</volume><issue>1-2</issue><fpage>101</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">1939502</pub-id></element-citation><mixed-citation publication-type="other" id="B8-gen-3">8. Kuno G, G&#x000f3;mez I, Gubler DJ. An ELISA procedure for the diagnosis of dengue infections. J Virol Methods. 1991;33(1-2):101-13.</mixed-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="book" id="B9-gen-2"><person-group person-group-type="author"><name><surname>Gubler</surname><given-names>DJ</given-names></name><name><surname>Sather</surname><given-names>GE</given-names></name></person-group><chapter-title>Laboratory diagnosis of dengue and dengue hemorrhagic fever</chapter-title><person-group person-group-type="editor"><name><surname>Homma</surname><given-names>A</given-names></name><name><surname>Cunha</surname><given-names>JF</given-names></name></person-group><source>Proceedings of the International Symposium on Yellow Fever and Dengue</source><year>1988</year><fpage>291</fpage><lpage>322</lpage></element-citation><mixed-citation publication-type="other" id="B9-gen-3">9. Gubler DJ, Sather GE. Laboratory diagnosis of dengue and dengue hemorrhagic fever. In: Homma A, Cunha JF, editors. Proceedings of the International Symposium on Yellow Fever and Dengue. 1988. p. 291-322.</mixed-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal" id="B10-gen-2"><person-group person-group-type="author"><name><surname>Innis</surname><given-names>BL</given-names></name><name><surname>Nisalak</surname><given-names>A</given-names></name><name><surname>Nimmannitya</surname><given-names>S</given-names></name><name><surname>Kusalerdchariya</surname><given-names>S</given-names></name><name><surname>Chongswasdi</surname><given-names>V</given-names></name><name><surname>Suntayakorn</surname><given-names>S</given-names></name><etal/></person-group><article-title>An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate</article-title><source>Am J Trop Med Hyg</source><year>1989</year><volume>40</volume><issue>4</issue><fpage>418</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">2540664</pub-id></element-citation><mixed-citation publication-type="other" id="B10-gen-3">10. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg. 1989;40(4):418-27.</mixed-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal" id="B11-gen-2"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>SK</given-names></name><name><surname>Devi</surname><given-names>S</given-names></name><name><surname>Pang</surname><given-names>T</given-names></name></person-group><article-title>Detection of specific IgM in dengue infections</article-title><source>Southeast Asian J Trop Med Public Health</source><year>1987</year><volume>18</volume><issue>4</issue><fpage>532</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">3329413</pub-id></element-citation><mixed-citation publication-type="other" id="B11-gen-3">11. Lam SK, Devi S, Pang T. Detection of specific IgM in dengue infections. Southeast Asian J Trop Med Public Health. 1987;18(4):532-8.</mixed-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal" id="B12-gen-2"><person-group person-group-type="author"><name><surname>Vene</surname><given-names>S</given-names></name><name><surname>Mangiafico</surname><given-names>J</given-names></name><name><surname>Niklasson</surname><given-names>B</given-names></name></person-group><article-title>Indirect immunofluorescence for serological diagnosis of dengue virus infections in Swedish patients</article-title><source>Clin Diagn Virol</source><year>1995</year><volume>4</volume><issue>1</issue><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">15566826</pub-id></element-citation><mixed-citation publication-type="other" id="B12-gen-3">12. Vene S, Mangiafico J Niklasson B. Indirect immunofluorescence for serological diagnosis of dengue virus infections in Swedish patients. Clin Diagn Virol. 1995;4(1):43-50.</mixed-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal" id="B13-gen-2"><person-group person-group-type="author"><name><surname>Sucipto</surname><given-names>TH</given-names></name><name><surname>Ahwanah</surname><given-names>NL</given-names></name><name><surname>Churrotin</surname><given-names>S</given-names></name><name><surname>Matake</surname><given-names>N</given-names></name><name><surname>Kotaki</surname><given-names>T</given-names></name><name><surname>Soegijanto</surname><given-names>S</given-names></name></person-group><article-title>Immunofluorescence assay method to detect dengue virus in Paniai-Papua</article-title><source>AIP Conference Proceedings</source><year>2016</year><volume>1718</volume><issue>1</issue><elocation-id>id.040001</elocation-id></element-citation><mixed-citation publication-type="other" id="B13-gen-3">13. Sucipto TH, Ahwanah NL, Churrotin S, Matake N, Kotaki T, Soegijanto S. Immunofluorescence assay method to detect dengue virus in Paniai-Papua. AIP Conference Proceedings. 2016;1718(1):id.040001.</mixed-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal" id="B14-gen-2"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>DA</given-names></name><name><surname>Depelsenaire</surname><given-names>AC</given-names></name><name><surname>Young</surname><given-names>PR</given-names></name></person-group><article-title>Clinical and Laboratory Diagnosis of Dengue Virus Infection</article-title><source>J Infect Dis</source><year>2017</year><volume>215</volume><issue>Suppl_2</issue><fpage>S89</fpage><lpage>S95</lpage><comment>Review</comment><pub-id pub-id-type="pmid">28403441</pub-id></element-citation><mixed-citation publication-type="other" id="B14-gen-3">14. Muller DA, Depelsenaire AC, Young PR. Clinical and Laboratory Diagnosis of Dengue Virus Infection. J Infect Dis. 2017;215(Suppl_2):S89-95. Review.</mixed-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal" id="B15-gen-2"><person-group person-group-type="author"><name><surname>Gart</surname><given-names>JJ</given-names></name><name><surname>Buck</surname><given-names>AA</given-names></name></person-group><article-title>Comparison of a screening test and a reference test in epidemiologic studies. II. A probabilistic model for the comparison of diagnostic tests</article-title><source>Am J Epidemiol</source><year>1996</year><volume>83</volume><issue>3</issue><fpage>593</fpage><lpage>602</lpage></element-citation><mixed-citation publication-type="other" id="B15-gen-3">15. Gart JJ, Buck AA. Comparison of a screening test and a reference test in epidemiologic studies. II. A probabilistic model for the comparison of diagnostic tests. Am J Epidemiol. 1996;83(3):593-602.</mixed-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal" id="B16-gen-2"><person-group person-group-type="author"><name><surname>Landis</surname><given-names>JR</given-names></name><name><surname>Koch</surname><given-names>GG</given-names></name></person-group><article-title>The measurement of observer agreement for categorical data</article-title><source>Biometrics</source><year>1977</year><volume>33</volume><issue>1</issue><fpage>159</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">843571</pub-id></element-citation><mixed-citation publication-type="other" id="B16-gen-3">16. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74.</mixed-citation></ref></ref-list></back><sub-article id="S01" article-type="translation" xml:lang="pt"><front-stub><article-categories><subj-group subj-group-type="heading"><subject>Artigo Original</subject></subj-group></article-categories><title-group><article-title>Avalia&#x000e7;&#x000e3;o do desempenho de <italic>kit</italic> de imunofluoresc&#x000ea;ncia indireta para o diagn&#x000f3;stico sorol&#x000f3;gico de dengue</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2929-5394</contrib-id><name><surname>Arai</surname><given-names>Karina Emy</given-names></name><xref ref-type="aff" rid="aff3"><sup>1</sup></xref><xref ref-type="corresp" rid="c2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9267-3282</contrib-id><name><surname>Bo</surname><given-names>Carolina Rodrigues Dal</given-names></name><xref ref-type="aff" rid="aff3"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0281-4302</contrib-id><name><surname>Silva</surname><given-names>Ana Paula Marques Aguirra da</given-names></name><xref ref-type="aff" rid="aff4"><sup>2</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6619-7836</contrib-id><name><surname>Rodrigues</surname><given-names>Silvia Sanches</given-names></name><xref ref-type="aff" rid="aff4"><sup>2</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4227-3723</contrib-id><name><surname>Mangueira</surname><given-names>Crist&#x000f3;v&#x000e3;o Luis Pitangueira</given-names></name><xref ref-type="aff" rid="aff4"><sup>2</sup></xref></contrib><aff id="aff3">
<label>1</label>
Faculdade Israelita de Ci&#x000ea;ncias da Sa&#x000fa;de Albert Einstein, Hospital Israelita Albert Einstein, S&#x000e3;o Paulo, SP, Brasil</aff><aff id="aff4">
<label>2</label>
Hospital Israelita Albert Einstein, S&#x000e3;o Paulo, SP, Brasil</aff></contrib-group><author-notes><corresp id="c2"><bold>Autor correspondente:</bold> Karina Emy Arai, Rua Madre Cabrini, 332 &#x02013; Vila Mariana CEP: <postal-code>04020-001</postal-code>d &#x02013; S&#x000e3;o Paulo, SP, Brasil Tel.: <phone>(11) 98999-4555</phone> E-mail: <email>karinaemyarai@gmail.com</email></corresp><fn fn-type="COI-statement"><p><bold>Conflitos de interesse:</bold> n&#x000e3;o h&#x000e1;.</p></fn></author-notes><abstract><title>RESUMO</title><sec><title>Objetivo:</title><p>Avaliar o desempenho da imunofluoresc&#x000ea;ncia indireta no diagn&#x000f3;stico sorol&#x000f3;gico de dengue em uma popula&#x000e7;&#x000e3;o com alta preval&#x000ea;ncia de arboviroses.</p></sec><sec><title>M&#x000e9;todos:</title><p>Duzentas amostras de soro de pacientes com suspeita cl&#x000ed;nica de dengue foram testadas por ensaio imunoenzim&#x000e1;tico e imunofluoresc&#x000ea;ncia indireta mosaico BIOCHIP<sup>&#x000ae;</sup>. Foram calculados especificidade, sensibilidade e coeficiente Kappa. Nas amostras discordantes, realizou-se rea&#x000e7;&#x000e3;o em cadeia da polimerase como m&#x000e9;todo confirmat&#x000f3;rio.</p></sec><sec><title>Resultados:</title><p>Das 200 amostras, 20% foram positivas e 80% negativas para IgM antiv&#x000ed;rus da dengue no ensaio imunoenzim&#x000e1;tico. Das 40 positivas, 25% foram negativas na imunofluoresc&#x000ea;ncia indireta. Destas dez negativas, apenas 20% eram tamb&#x000e9;m negativas na rea&#x000e7;&#x000e3;o em cadeia da polimerase. Das 160 negativas no ensaio imunoenzim&#x000e1;tico, 5% foram positivas na imunofluoresc&#x000ea;ncia indireta. Por fim, dentre as nove discordantes, 33% tiveram v&#x000ed;rus da dengue detectado na rea&#x000e7;&#x000e3;o em cadeia da polimerase. O coeficiente Kappa foi 0,70 (0,57-0,82). Sensibilidade e especificidade por imunofluoresc&#x000ea;ncia indireta foram, respectivamente, 75% e 94%. Para IgG antiv&#x000ed;rus da dengue, de 200 amostras, 15,5% foram positivas e 84,5% negativas no ensaio imunoenzim&#x000e1;tico. Das 31 positivas, 12,9% foram negativas na imunofluoresc&#x000ea;ncia indireta. Destas quatro discordantes, 25% apresentaram v&#x000ed;rus da dengue n&#x000e3;o detectado na rea&#x000e7;&#x000e3;o em cadeia da polimerase. Das 169 negativas, 8% foram positivas na imunofluoresc&#x000ea;ncia indireta. Destas, 64% foram positivas tamb&#x000e9;m na rea&#x000e7;&#x000e3;o em cadeia da polimerase. O coeficiente Kappa foi 0,695 (0,56-0,83). Sensibilidade e a especificidade por imunofluoresc&#x000ea;ncia indireta foram, respectivamente, 87,1% e 91,7%.</p></sec><sec><title>Conclus&#x000e3;o:</title><p>Ensaio imunoenzim&#x000e1;tico seria suficiente para diagn&#x000f3;stico sorol&#x000f3;gico de infec&#x000e7;&#x000e3;o aguda, n&#x000e3;o justificando a incorpora&#x000e7;&#x000e3;o da imunofluoresc&#x000ea;ncia indireta. Substituir ensaio imunoenzim&#x000e1;tico pela imunofluoresc&#x000ea;ncia indireta poderia comprometer a sensibilidade para IgM. Contudo, a imunofluoresc&#x000ea;ncia indireta auxilia diferenciar tr&#x000ea;s arboviroses simultaneamente, sendo vantajoso em epidemias concomitantes.</p></sec></abstract><kwd-group xml:lang="pt"><title>Descritores:</title><kwd>Infec&#x000e7;&#x000f5;es por arbov&#x000ed;rus</kwd><kwd>Dengue</kwd><kwd>Ensaio de imunoadsor&#x000e7;&#x000e3;o enzim&#x000e1;tica</kwd><kwd>Testes sorol&#x000f3;gicos</kwd><kwd>T&#x000e9;cnica indireta de fluoresc&#x000ea;ncia para anticorpo</kwd></kwd-group></front-stub><body><sec sec-type="intro"><title>INTRODU&#x000c7;&#x000c3;O</title><p>A dengue, uma arbovirose transmitida predominantemente por vetores da esp&#x000e9;cie <italic>Aedes aegypti</italic>, &#x000e9; um grave problema de sa&#x000fa;de p&#x000fa;blica no Brasil, causando epidemias sazonais em praticamente todo o territ&#x000f3;rio nacional.<sup>(</sup><xref rid="B1" ref-type="bibr"><sup>1</sup></xref><sup>)</sup> Foram registrados, no pa&#x000ed;s, 572.308 casos prov&#x000e1;veis em 2014, 1.621.797 em 2015, 1.483.623 em 2016, 251.711 em 2017 e 265.934 em 2018.<sup>(</sup><xref rid="B2" ref-type="bibr"><sup>2</sup></xref><sup>&#x02013;</sup><xref rid="B4" ref-type="bibr"><sup>4</sup></xref><sup>)</sup> Todos os quatro sorotipos do v&#x000ed;rus da dengue s&#x000e3;o encontrados no Brasil.</p><p>O diagn&#x000f3;stico laboratorial de dengue envolve principalmente t&#x000e9;cnicas como isolamento viral, identifica&#x000e7;&#x000e3;o de anticorpos espec&#x000ed;ficos para o v&#x000ed;rus da dengue (DENV) pelos testes sorol&#x000f3;gicos, identifica&#x000e7;&#x000e3;o direta do RNA viral e detec&#x000e7;&#x000e3;o do ant&#x000ed;geno NS1.<sup>(</sup><xref rid="B5" ref-type="bibr"><sup>5</sup></xref><sup>&#x02013;</sup><xref rid="B7" ref-type="bibr"><sup>7</sup></xref><sup>)</sup></p><p>O diagn&#x000f3;stico sorol&#x000f3;gico da infec&#x000e7;&#x000e3;o aguda se baseia na detec&#x000e7;&#x000e3;o da imunoglobulina M (IgM) espec&#x000ed;fica para DENV, que &#x000e9; detect&#x000e1;vel, em 93% dos casos, entre 6 a 10 dias ap&#x000f3;s o aparecimento da febre.<sup>(</sup><xref rid="B8" ref-type="bibr"><sup>8</sup></xref><sup>)</sup> A imunoglobulina G (IgG) espec&#x000ed;fica para DENV pode ser identificada em infec&#x000e7;&#x000f5;es atuais se, no momento da realiza&#x000e7;&#x000e3;o do teste, j&#x000e1; tiver ocorrido a soroconvers&#x000e3;o, sendo &#x000fa;til para identifica&#x000e7;&#x000e3;o de infec&#x000e7;&#x000f5;es passadas de dengue. O teste de avidez de IgG auxilia na diferencia&#x000e7;&#x000e3;o entre infec&#x000e7;&#x000e3;o prim&#x000e1;ria ou secund&#x000e1;ria de dengue.<sup>(</sup><xref rid="B6" ref-type="bibr"><sup>6</sup></xref><sup>)</sup></p><p>O ensaio imunoenzim&#x000e1;tico (ELISA - <italic>Enzyme-Linked Immunosorbent Assay</italic>) se tornou o teste sorol&#x000f3;gico mais utilizado nos laborat&#x000f3;rios cl&#x000ed;nicos. &#x000c9; um teste simples, r&#x000e1;pido e que requer poucos equipamentos de alta tecnologia.<sup>(</sup><xref rid="B9" ref-type="bibr"><sup>9</sup></xref><sup>&#x02013;</sup><xref rid="B11" ref-type="bibr"><sup>11</sup></xref><sup>)</sup> Durante uma epidemia, o ELISA consegue determinar rapidamente o qu&#x000e3;o difundida a transmiss&#x000e3;o se tornou. Em &#x000e1;reas end&#x000ea;micas de dengue, esse teste pode ser usado para rastreio de um grande n&#x000fa;mero de amostras sorol&#x000f3;gicas a baixo custo.<sup>(</sup><xref rid="B9" ref-type="bibr"><sup>9</sup></xref><sup>)</sup></p><p>A imunofluoresc&#x000ea;ncia indireta &#x000e9; outro m&#x000e9;todo sorol&#x000f3;gico que pode ser usado para identificar IgM e IgG espec&#x000ed;ficos para dengue, e h&#x000e1; poucos estudos<sup>(</sup><xref rid="B12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="B13" ref-type="bibr"><sup>13</sup></xref><sup>)</sup> que avaliam o uso desse teste. A maioria dos testes sorol&#x000f3;gicos dispon&#x000ed;veis nos laborat&#x000f3;rios cl&#x000ed;nicos brasileiros foi desenvolvida fora do pa&#x000ed;s, com estudos de valida&#x000e7;&#x000e3;o frequentemente realizados em popula&#x000e7;&#x000f5;es de baixa preval&#x000ea;ncia da doen&#x000e7;a e que n&#x000e3;o experimentaram surtos concomitantes de outras arboviroses, como Zika ou Chikungunya, que podem levar a resultados falso-positivos de dengue por rea&#x000e7;&#x000e3;o cruzada de anticorpos, dificultando seu diagn&#x000f3;stico.<sup>(</sup><xref rid="B14" ref-type="bibr"><sup>14</sup></xref><sup>)</sup></p><p>Durante o surto epid&#x000ea;mico de dengue em 2016, um novo teste comercial de imunofluoresc&#x000ea;ncia indireta (IFI) mosaico BIOCHIP<sup>&#x000ae;</sup>, que promete diferenciar sorologicamente infec&#x000e7;&#x000f5;es por dengue, Zika e Chikungunya, desenvolvido na Alemanha, foi lan&#x000e7;ado no mercado brasileiro, competindo com os testes de ELISA utilizados rotineiramente h&#x000e1; mais tempo.</p></sec><sec><title>OBJETIVO</title><p>Avaliar o desempenho diagn&#x000f3;stico de um teste de imunofluoresc&#x000ea;ncia indireta para o diagn&#x000f3;stico sorol&#x000f3;gico de dengue em uma popula&#x000e7;&#x000e3;o com alta preval&#x000ea;ncia de infec&#x000e7;&#x000f5;es por arbov&#x000ed;rus comparando com o teste sorol&#x000f3;gico ELISA.</p></sec><sec sec-type="methods"><title>M&#x000c9;TODOS</title><p>Foram utilizadas 200 amostras de soro provenientes da rotina do Laborat&#x000f3;rio Cl&#x000ed;nico do Hospital Israelita Albert Einstein (HIAE), colhidas no ano de 2014 e encaminhadas ao laborat&#x000f3;rio, ap&#x000f3;s suspeita cl&#x000ed;nica de infec&#x000e7;&#x000e3;o por dengue. As amostras foram caracterizadas &#x000e0; &#x000e9;poca como negativas ou positivas para dengue por ELISA (Foccus, EUA). Todas as amostras foram testadas pelo teste de IFI Mosaico BIOCHIP<sup>&#x000ae;</sup> (Euroimmun, Alemanha).</p><p>Utilizando ferramentas estat&#x000ed;sticas adequadas (software EP Evaluator), foram calculadas as probabilidades pr&#x000e9;-teste: sensibilidade (capacidade que o teste diagn&#x000f3;stico apresenta de detectar os indiv&#x000ed;duos verdadeiramente positivos) e especificidade (capacidade que o teste diagn&#x000f3;stico tem de detectar os verdadeiros negativos). Tamb&#x000e9;m foram calculadas probabilidades p&#x000f3;s-teste: valor preditivo positivo (propor&#x000e7;&#x000e3;o de pacientes com teste positivo que efetivamente t&#x000ea;m a doen&#x000e7;a de acordo com o teste padr&#x000e3;o-ouro), valor preditivo negativo (propor&#x000e7;&#x000e3;o de pacientes que s&#x000e3;o negativos no teste e que efetivamente n&#x000e3;o t&#x000ea;m a doen&#x000e7;a de acordo com o teste padr&#x000e3;o-ouro). Por fim, foram calculados a acur&#x000e1;cia, que &#x000e9; a probabilidade de o teste fornecer resultados corretos, e o coeficiente Kappa, uma medida de concord&#x000e2;ncia entre dois m&#x000e9;todos ajustada pela chance, ou seja, informa a propor&#x000e7;&#x000e3;o de concord&#x000e2;ncia n&#x000e3;o aleat&#x000f3;ria, variando de &#x02212;1 a 1, sendo, 0,00 para nenhuma concord&#x000e2;ncia, 0,00-0,20 para concord&#x000e2;ncia fraca, 0,21-0,40 para concord&#x000e2;ncia sofr&#x000ed;vel, 0,41-0,60 para concord&#x000e2;ncia regular, 0,61-0,80 para boa concord&#x000e2;ncia, 0,81-0,99 para &#x000f3;tima concord&#x000e2;ncia e 1 para concord&#x000e2;ncia perfeita.<sup>(</sup><xref rid="B15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="B16" ref-type="bibr"><sup>16</sup></xref><sup>)</sup></p><p>Nas amostras discordantes entre os dois m&#x000e9;todos, realizou-se a pesquisa do v&#x000ed;rus por rea&#x000e7;&#x000e3;o em cadeia da polimerase (PCR) como m&#x000e9;todo diagn&#x000f3;stico confirmat&#x000f3;rio. O PCR &#x000e9; um teste molecular que faz uma detec&#x000e7;&#x000e3;o quantitativa do RNA do DENV, sendo considerado o padr&#x000e3;o-ouro, uma vez que comprova a presen&#x000e7;a viral no organismo. Contudo, apresenta desvantagem, como possuir um alto custo, o que impede seu uso rotineiro como rastreio nos laborat&#x000f3;rios.<sup>(</sup><xref rid="B5" ref-type="bibr"><sup>5</sup></xref><sup>)</sup></p><p>Este estudo foi aprovado pelo Comit&#x000ea; de &#x000c9;tica em Pesquisa do Hospital Israelita Albert Einstein, CAAE: 83521718.5.0000.0071, parecer n&#x000fa;mero 2.909.625.</p></sec><sec sec-type="results"><title>RESULTADOS</title><p>Das 200 amostras estudadas, 40 (20%) foram classificadas como positivas e 160 (80%) como negativas para anticorpos IgM contra o DENV (anti-DENV), empregando-se o teste de refer&#x000ea;ncia ELISA.</p><p>Entre as 40 amostras positivas, 10 (25%) foram negativas no teste de IFI; destas 10 amostras discordantes, apenas 2 (20%) eram tamb&#x000e9;m negativas para dengue ao PCR. Por outro lado, das 160 amostras negativas no teste de refer&#x000ea;ncia ELISA, 9 (5%) foram positivas quando se empregou o teste de IFI; dessas 9 discordantes, 3 (33%) tiveram DENV detectado ao PCR (<xref rid="t3" ref-type="table">Tabela 1</xref>).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Tabela 1</label><caption><title>Detec&#x000e7;&#x000e3;o de anticorpos IgM antiv&#x000ed;rus da dengue por meio do teste de ELISA e da imunofluoresc&#x000ea;ncia indireta</title></caption><table frame="hsides" rules="groups"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr style="background-color:#ADC9EA"><th align="left" rowspan="2" valign="middle" colspan="1">Imunofluoresc&#x000ea;ncia indireta IgM</th><th align="center" colspan="2" style="border-bottom: thin solid; border-color: #000000" rowspan="1">ELISA IgM</th><th align="center" rowspan="2" valign="middle" colspan="1">Total</th></tr><tr style="background-color:#ADC9EA"><th align="center" rowspan="1" colspan="1">Positivo</th><th align="center" rowspan="1" colspan="1">Negativo</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr style="background-color:#E1ECF8"><td align="left" rowspan="1" colspan="1">Positivo</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">39</td></tr><tr><td align="left" rowspan="1" colspan="1">Negativo</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">151</td><td align="center" rowspan="1" colspan="1">161</td></tr><tr style="background-color:#E1ECF8"><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">160</td><td align="center" rowspan="1" colspan="1">200</td></tr></tbody></table></table-wrap><p>Aplicando-se o teste Kappa ao conjunto de resultados dos dois ensaios, observou-se &#x000ed;ndice de concord&#x000e2;ncia de 0,7 (0,572-0,829). A sensibilidade e a especificidade relativas da IFI foram, respectivamente, 75% e de 94%. O valor preditivo positivo da IFI foi 76,9%, o valor preditivo negativo da IFI foi 93,7% e a acur&#x000e1;cia, 90,5%.</p><p>Para anticorpos IgG anti-DENV, de 200 amostras de soro, 31 (15,5%) foram classificadas como positivas e 169 (84,5%) como negativas, empregando-se o teste de ELISA. Das 31 amostras positivas, 4 (12,9%) foram negativas no teste de IFI; dessas 4 discordantes, apenas 1 (25%) apresentou DENV n&#x000e3;o detectado ao PCR. Por outro lado, das 169 amostras negativas, 14 (8%) foram positivas no teste de IFI avaliado; destas 14 discordantes, 9 (64%) foram positivas tamb&#x000e9;m ao PCR (<xref rid="t4" ref-type="table">Tabela 2</xref>).</p><table-wrap id="t4" orientation="portrait" position="float"><label>Tabela 2</label><caption><title>Detec&#x000e7;&#x000e3;o de anticorpos IgG antiv&#x000ed;rus da dengue. Compara&#x000e7;&#x000e3;o entre resultados obtidos empregando-se ELISA e imunofluoresc&#x000ea;ncia indireta</title></caption><table frame="hsides" rules="groups"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr style="background-color:#ADC9EA"><th align="left" rowspan="2" valign="middle" colspan="1">Imunofluoresc&#x000ea;ncia Indireta IgG</th><th align="center" colspan="2" style="border-bottom: thin solid; border-color: #000000" rowspan="1">ELISA IgG</th><th align="center" rowspan="2" valign="middle" colspan="1">Total</th></tr><tr style="background-color:#ADC9EA"><th align="center" rowspan="1" colspan="1">Reagente</th><th align="center" rowspan="1" colspan="1">N&#x000e3;o reagente</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr style="background-color:#E1ECF8"><td align="left" rowspan="1" colspan="1">Reagente</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">41</td></tr><tr><td align="left" rowspan="1" colspan="1">N&#x000e3;o reagente</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">155</td><td align="center" rowspan="1" colspan="1">159</td></tr><tr style="background-color:#E1ECF8"><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">169</td><td align="center" rowspan="1" colspan="1">200</td></tr></tbody></table></table-wrap><p>Aplicando-se o teste Kappa ao conjunto de resultados dos dois ensaios, observou-se &#x000ed;ndice de concord&#x000e2;ncia de 0,695 (0,563-0,83). A sensibilidade e a especificidade relativas da IFI foram, respectivamente, de 87,1% e de 91,7%. O valor preditivo positivo da IFI foi 65,8%, o valor preditivo negativo da IFI foi 97,4% e a acur&#x000e1;cia, 91%.</p></sec><sec sec-type="discussion"><title>DISCUSS&#x000c3;O</title><p>A concord&#x000e2;ncia, verificada pelo &#x000ed;ndice Kappa, entre o novo teste realizado por IFI e o teste utilizado como refer&#x000ea;ncia ELISA foi aceit&#x000e1;vel, demonstrando bom desempenho do novo teste.</p><p>Entretanto, a compara&#x000e7;&#x000e3;o com os resultados de PCR, m&#x000e9;todo utilizado como confirmat&#x000f3;rio da presen&#x000e7;a de ant&#x000ed;genos virais nas amostras com resultados discordantes entre os dois m&#x000e9;todos, demonstrou maior concord&#x000e2;ncia com o ELISA na maioria dos casos, exceto nos casos negativos por ELISA e positivos por IFI para anticorpos IgG anti-DENV (falso-positivos IgG), em que o resultado do PCR foi 64% coincidente com a imunofluoresc&#x000ea;ncia indireta.</p></sec><sec sec-type="conclusions"><title>CONCLUS&#x000c3;O</title><p>A imunofluoresc&#x000ea;ncia indireta possui desempenho aceit&#x000e1;vel, mas, para as situa&#x000e7;&#x000f5;es de relev&#x000e2;ncia cl&#x000ed;nica, no diagn&#x000f3;stico de infec&#x000e7;&#x000e3;o aguda (detec&#x000e7;&#x000e3;o de anticorpos IgM), a utiliza&#x000e7;&#x000e3;o apenas do teste de ELISA seria suficiente para o diagn&#x000f3;stico sorol&#x000f3;gico, n&#x000e3;o se justificando a incorpora&#x000e7;&#x000e3;o de mais um m&#x000e9;todo. Por outro lado, a substitui&#x000e7;&#x000e3;o do teste de ELISA pela imunofluoresc&#x000ea;ncia indireta poderia comprometer a sensibilidade diagn&#x000f3;stica, aumentando o n&#x000fa;mero de amostras falso-negativas para IgM.</p></sec></body></sub-article></article>